William Francis Selde, MD | |
Psc 819 18 Fpo Ae 09645 Hospital Americano Base Nav, Rota, Fpo, AE 09645 | |
(314) 727-3524 | |
Not Available |
Full Name | William Francis Selde |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | Psc 819 18 Fpo Ae 09645 Hospital Americano Base Nav, Fpo, Armed Forces Europe |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417268939 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
William Francis Selde, MD Psc 819 Box 18, Fpo, AE 09645-0001 Ph: () - | William Francis Selde, MD Psc 819 18 Fpo Ae 09645 Hospital Americano Base Nav, Rota, Fpo, AE 09645 Ph: (314) 727-3524 |
News Archive
Individuals suffering from chronic obstructive pulmonary disorder (COPD) can experience significant savings in healthcare costs by employing a self-treatment program with the judicious use of medications, according to the results of a new study. The self-treatment program achieves these savings by reducing the duration of flare-ups.
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Beta-2 microglobulin as a Biomarker for Peripheral Artery Disease."
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
People with newly diagnosed epilepsy experienced few, if any, seizures while taking the drug levetiracetam as a single therapy, giving hope to epilepsy patients who don't respond to or can't tolerate existing treatments, according to a study published in the February 6, 2007 issue of Neurology, the scientific journal of the American Academy of Neurology.
A just-released study by UT Health San Antonio and collaborating institutions shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin.
› Verified 7 days ago
Ronald Christopher Fenton, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: Psc 836, Fpo, AE 09636 Phone: 314-624-3842 | |
Dr. Guillermo Alberto Navarro, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Psc 819 Box 4488, Fpo, AE 09645 Phone: 943-472-73307 | |
Dr. Peter Gael Woodson, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Us Naval Hospital, Naples, Psc 827 Box 72, Fpo, AE 09617 Phone: 390-818-116150 | |
Dr. Tara Jean Zieber, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: Psc 819 Box 18 #194, Fpo, AE 09645 Phone: 011-349-56823307 |